The method and apparatus generally relate to skin treatment procedures and in particular to cosmetic skin resurfacing and rejuvenation procedures.
Fractional skin resurfacing or rejuvenation is a recently developed skin ablative technology. There are two types of devices used to ablate the skin: laser based devices and RF based devices. Both types of these devices ablate a pattern of extremely small diameter shallow holes or zones. The holes are microscopically small treatment zones surrounded by untreated skin areas. The treatment results in a very rapid healing or recovery and skin resurfacing of the treated. In the healing process of the treated zones, a layer of new skin appears, restoring a fresh, youthful complexion.
The pattern of small holes is typically produced by an X-Y scanning laser beam or by application of RF energy or voltage. The laser is focused on the skin and usually operates in pulse mode ablating micron size holes in the skin.
RF based fractional skin treatment produces a scanning pattern of micron size holes in the skin a similar to laser. Typically, the energy is delivered to the skin by an applicator equipped by a tip having a plurality of voltage to skin applying/delivering elements or contact elements arranged in a matrix or in an array. The voltage to skin applying elements are placed in contact with the segment of the skin to be treated and driven by a source of suitable power and frequency RF energy. Application of a high voltage RF pulse to the electrodes ablates the skin under the respective electrode forming a small hole.
In some instances application of laser or RF voltage pulses causes discomfort and even pain to the treated subject, although the experience based on the individual and as such, the pain sensation may be different from subject to subject. In other instances there may be a difference in the size of micro holes formed by the applicator at the same treatment session. Healing of larger size holes may take a longer period of time than the healing process for smaller size holes and in some instances, the larger holes may tend to result in causing damage to the skin rather than producing the desired skin effect.
In order to soften the discomfort and lessen the pain and other side effects associated with the fractional treatment, practitioners have started using topically applied lidocaine cream or even oral sedation.
Fractional skin treatment is applicable in the correction of almost all cosmetic skin defects such as signs of aging, wrinkles, discolorations, acne scars, tattoo removal, and other skin defects. The cost of the RF based products is lower than that of the products operating with laser radiation and they will most probably become widely used if the discomfort and occasional pain associated with their use could be eliminated.
US Patent Application Publication No. 2006/0047281 and U.S. patent application Ser. No. 12/324,932 to the same assignee disclose RF based products such as eMatrix™ suitable for fractional skin treatment.
In the context of the present disclosure “RF voltage” and “RF energy” are used interchangeably and have the same meaning. The mathematical relationship between these two parameters is well known and knowledge of one of them allows easy determination of the other.
In the context of the present disclosure “skin resistance” and “skin impedance” are used interchangeably and have the same meaning. The mathematical relation between these two parameters is well known and knowledge of one of them allows easy determination of the other.
The term “desired skin effect” as used in the present disclosure means a result of RF energy application, which may be wrinkle removal, hair removal, collagen shrinking or destruction, skin rejuvenation, and other cosmetic and skin treatments.
The term “plateau” of a function is a part of its domain where the function has constant value.
An apparatus for cosmetic RF skin treatment where the RF energy supply is isolated from the subject treated, such that in course of treatment no undesired current flows through the subject body. The apparatus includes an applicator with a tip that is populated by a plurality of voltage applying dome shaped elements protruding from the tip surface and organized in one common cluster and a cluster of electrodes bounding the dome shaped elements and having an area larger than the dome shaped elements have. The apparatus applies voltage to the elements with a magnitude sufficient to cause a desired skin effect. A current limiter limits the RF induced current thereby preventing skin damage. The apparatus continuously senses the treated skin segment impedance and varies the RF energy at a low skin impedance and/or stops the pulse in cases of too low or too high skin impedance.
The principles and execution of the method and the apparatus may be better understood with reference to the drawings and the accompanying description of the non-limiting, exemplary embodiments, shown in the Figures.
Reference is made to
Referring to
Because not all of the voltage to skin delivering elements or contact elements 330 (
In order to resolve this problem, as disclosed in the U.S. patent application Ser. No. 12/324,932 assigned to the same assignee, it is possible to address individually each contact element or pin and connect it to the source of voltage through a large impedance, which can be a resistor, a small capacitor, a large inductor, or a combinations of all of them. This would stabilize the RF induced current to each individual channel reducing the “competition” between the contact elements and clusters of contact elements. For sterilization and hygiene purposes use of disposable tips is preferred to the use of reusable tips. Addressing of each individual contact element however, complicates and increases manufacturing cost of such tips.
Another way to equalize the resistance or impedance of each contact element and reduce the pain sensation and potential electric shocks to the treated subject is to bring the skin by some initial treatment to an optimal and more uniform resistance value, which for example may be about 3000 Ohms There will always be however, segments of skin where the resistance is low and any slight sweating may drive the skin to lower impedances.
Electrical resistance of skin differs from subject to subject and complicates proper RF energy value selection and application of the RF energy for cosmetic skin treatment. Further to this, resistance of the subject may vary under application of RF energy.
In order to establish proper treatment parameters prior to the treatment, a system operator or user can calibrate the apparatus and operational treatment parameters derived as a result of the calibration are loaded into a look-up-table (LUT) that may be stored in the memory of the controller 432. For the purpose of calibration, a known variable resistance modeling the subject and the tip behavior is connected instead of a subject to the RF voltage supply. In one of the calibrations, a current flowing in the circuit at different RF voltages and different resistance value is recorded and in another calibration the RF energy applied to the variable resistance, modeling different skin impedance is recorded.
When skin is wet its resistance is low and with the application of the RF energy it continues to fall (line 606). Without being bound by a specific theory it is believed that most of the RF energy applied to the skin is initially wasted to dry the skin and when the skin under the influence of RF energy becomes dry, the skin resistance begins growing to higher values. Resistance increase is believed to be connected with vaporization, accompanied or followed by tissue ablation. It is considered a good treatment (desired skin effect) when ablation is created in the tissue below the electrodes.
It has been experimentally established that treatment resulting in a desired skin effect takes place when the resistance of the subject's skin is between Rlow and Rhigh, where the specific values depend on the number of electrodes in the tip and their arrangement and on the skin properties. For a typical tip shown in
It is possible to generalize the skin behavior under an RF pulse into at least two typical cases, although a mixture of these cases and other skin behavior may be present: a) skin resistance remains high through all of the RF pulse application time and b) skin resistance drops down below the lower resistance limit and after it reaches (the function reaches) a plateau it begins to rise. Accordingly, by monitoring the current flowing in the voltage to skin delivering elements circuit, it is possible to set proper treatment parameters resulting in a desired skin effect and not causing adverse side effects such as pain, burnings and other. It was found that resistances above Rhigh correspond to dirty tip and/or are caused by improper attachment of the tip to the skin. In both cases, the pulses may cause undesired pain. In order to reduce the pain, current limiter 704 (
The electric scheme and the tip structure disclosed above eliminate electrical shock feeling, reduce or eliminate the pain associated with the treatment and increase the treatment efficacy. The isolating transformer is located very close to the application tip to reduce ground currents through parasitic capacitance. Series capacitors located in the path to the electrodes filter out low frequency currents which are produced by plasma formed at the electrodes and fast current limiter sets a maximum to the current which flows into the skin.
Typical operating parameters of the apparatus are:
Voltage on high impedance load: 850 Vp-p
Current: 50-400 mA
Pulse length: 10-150 msec
Energy per pulse (Actual energy delivered to the skin): 0.5-4 J, more typical 1-2 J.
Frequency of the RF: 1 MHz, although 100 kHz up to 10 MHz may be considered.
Typical control parameters for the asymmetrical tip, 64 pins, 250 microns each:
High resistance limit for cutting of pulses for pain reduction: >1600 Ohms (for 64 pins asymmetrical tip)
Low resistance limit for cutting low efficiency pulses: <200 Ohms (for 64 pins asymmetrical tip)
Range of resistance where control adds energy to dry the skin: 200-600 Ohms (for 64 pins asymmetrical tip)
This application is a continuation of U.S. application Ser. No. 14/252,832, filed on Apr. 15, 2014, now issued as U.S. Pat. No. 9,072,882, which is a continuation of U.S. application Ser. No. 13/400,434, filed on Feb. 20, 2012, which is a continuation of U.S. application Ser. No. 12/505,576, filed on Jul. 20, 2009, now issued as U.S. Pat. No. 8,357,150. The contents of these priority applications are incorporated herein by reference. This application is related to U.S. application Ser. No. 12/324,932, filed Nov. 28, 2008, now issued as U.S. Pat. No. 8,216,215, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4200104 | Harris | Apr 1980 | A |
4844063 | Clark | Jul 1989 | A |
5287380 | Hsia | Feb 1994 | A |
5312395 | Tan et al. | May 1994 | A |
5319363 | Welch et al. | Jun 1994 | A |
5320618 | Gustafsson | Jun 1994 | A |
5360425 | Cho | Nov 1994 | A |
5383874 | Jackson et al. | Jan 1995 | A |
5394492 | Hwang | Feb 1995 | A |
5598426 | Hsia et al. | Jan 1997 | A |
5599342 | Hsia et al. | Feb 1997 | A |
5681282 | Eggers et al. | Oct 1997 | A |
5755753 | Knowlton | May 1998 | A |
5766153 | Eggers et al. | Jun 1998 | A |
5789755 | Bender | Aug 1998 | A |
5814040 | Nelson et al. | Sep 1998 | A |
5820626 | Baumgardner | Oct 1998 | A |
5873855 | Eggers et al. | Feb 1999 | A |
5885274 | Fullmer et al. | Mar 1999 | A |
5968034 | Fullmer et al. | Oct 1999 | A |
5971982 | Betsill et al. | Oct 1999 | A |
5976123 | Baumgardner et al. | Nov 1999 | A |
5979454 | Anvari et al. | Nov 1999 | A |
5983135 | Avrahami | Nov 1999 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6026816 | McMillian et al. | Feb 2000 | A |
6028316 | Bender | Feb 2000 | A |
6059772 | Hsia et al. | May 2000 | A |
6117335 | Bender | Sep 2000 | A |
6120497 | Anderson et al. | Sep 2000 | A |
6132426 | Kroll | Oct 2000 | A |
6148232 | Avrahami | Nov 2000 | A |
6171301 | Nelson et al. | Jan 2001 | B1 |
6200308 | Pope et al. | Mar 2001 | B1 |
6200466 | Bender | Mar 2001 | B1 |
6235015 | Mead, III et al. | May 2001 | B1 |
6248103 | Tannenbaum et al. | Jun 2001 | B1 |
6273885 | Koop et al. | Aug 2001 | B1 |
6277116 | Utely et al. | Aug 2001 | B1 |
6328033 | Avrahami | Dec 2001 | B1 |
6364872 | Hsia et al. | Apr 2002 | B1 |
6402742 | Blewett | Jun 2002 | B1 |
6413253 | Koop et al. | Jul 2002 | B1 |
6413255 | Stern | Jul 2002 | B1 |
6440121 | Weber et al. | Aug 2002 | B1 |
6451007 | Koop et al. | Sep 2002 | B1 |
6512782 | Hsia et al. | Jan 2003 | B1 |
6514241 | Hsia et al. | Feb 2003 | B1 |
6514244 | Pope et al. | Feb 2003 | B2 |
6547786 | Goble | Apr 2003 | B1 |
6597946 | Avrahami et al. | Jul 2003 | B2 |
6605080 | Altshuler et al. | Aug 2003 | B1 |
6607498 | Eshel | Aug 2003 | B2 |
6611706 | Avrahami et al. | Aug 2003 | B2 |
6615079 | Avrahami | Sep 2003 | B1 |
6659999 | Anderson et al. | Dec 2003 | B1 |
6662054 | Kreindel et al. | Dec 2003 | B2 |
6702808 | Kreindel | Mar 2004 | B1 |
6708060 | Avrahami et al. | Mar 2004 | B1 |
6711435 | Avrahami | Mar 2004 | B2 |
6743222 | Durkin et al. | Jun 2004 | B2 |
6749624 | Knowlton | Jun 2004 | B2 |
6761826 | Bender | Jul 2004 | B2 |
6829260 | Hsia et al. | Dec 2004 | B2 |
6889090 | Kreindel | May 2005 | B2 |
6939344 | Kreindel | Sep 2005 | B2 |
7022121 | Stern et al. | Apr 2006 | B2 |
7041100 | Kreindel | May 2006 | B2 |
7060061 | Altshuler et al. | Jun 2006 | B2 |
7062317 | Avrahami et al. | Jun 2006 | B2 |
7094252 | Koop | Aug 2006 | B2 |
7122029 | Koop et al. | Oct 2006 | B2 |
7123957 | Avrahami | Oct 2006 | B2 |
7164942 | Avrahami et al. | Jan 2007 | B2 |
7184614 | Slatkine | Feb 2007 | B2 |
7217265 | Hennings et al. | May 2007 | B2 |
7238183 | Kreindel | Jul 2007 | B2 |
7241491 | Kreindel et al. | Jul 2007 | B2 |
7331951 | Eshel et al. | Feb 2008 | B2 |
7333698 | Israel | Feb 2008 | B2 |
7335377 | Stern et al. | Feb 2008 | B2 |
7347855 | Eshel et al. | Mar 2008 | B2 |
7363075 | Stern et al. | Apr 2008 | B2 |
7383084 | Stern et al. | Jun 2008 | B2 |
7395111 | Levin et al. | Jul 2008 | B2 |
7415306 | Levin et al. | Aug 2008 | B2 |
7435247 | Woloszko et al. | Oct 2008 | B2 |
7494488 | Weber | Feb 2009 | B2 |
7524316 | Hennings et al. | Apr 2009 | B2 |
7558625 | Levin et al. | Jul 2009 | B2 |
7637906 | Koop et al. | Dec 2009 | B2 |
7643883 | Kreindel | Jan 2010 | B2 |
7644715 | Hayes et al. | Jan 2010 | B2 |
7662404 | Stern et al. | Feb 2010 | B2 |
7671327 | Clancy et al. | Mar 2010 | B2 |
7709997 | Nudelman et al. | May 2010 | B2 |
7740651 | Barak et al. | Jun 2010 | B2 |
7762965 | Slatkine | Jul 2010 | B2 |
7815570 | Eshel et al. | Oct 2010 | B2 |
7824394 | Manstein | Nov 2010 | B2 |
7857775 | Rosenberg et al. | Dec 2010 | B2 |
7875023 | Eshel et al. | Jan 2011 | B2 |
7891362 | Domankevitz et al. | Feb 2011 | B2 |
7921854 | Hennings et al. | Apr 2011 | B2 |
7935139 | Slatkine | May 2011 | B2 |
7947304 | Sacks et al. | May 2011 | B2 |
7955262 | Rosenberg | Jun 2011 | B2 |
8007493 | McGill et al. | Aug 2011 | B2 |
8016810 | Levin et al. | Sep 2011 | B2 |
8041421 | Birchall et al. | Oct 2011 | B2 |
8127771 | Hennings | Mar 2012 | B2 |
8133191 | Rosenberg et al. | Mar 2012 | B2 |
8133216 | Knopp et al. | Mar 2012 | B2 |
8133505 | Stern et al. | Mar 2012 | B2 |
8135475 | Kreindel et al. | Mar 2012 | B2 |
8142426 | Knopp et al. | Mar 2012 | B2 |
8216215 | Flyash et al. | Jul 2012 | B2 |
8246611 | Paithankar et al. | Aug 2012 | B2 |
8256429 | Hennings et al. | Sep 2012 | B2 |
8273037 | Kreindel et al. | Sep 2012 | B2 |
8273080 | Mehta | Sep 2012 | B2 |
8276590 | Hennings et al. | Oct 2012 | B2 |
8277495 | Demetriou et al. | Oct 2012 | B2 |
8281675 | Levin et al. | Oct 2012 | B2 |
8328795 | Domankevitz et al. | Dec 2012 | B2 |
8337493 | Sohn | Dec 2012 | B2 |
D674485 | Flyash et al. | Jan 2013 | S |
8357146 | Hennings et al. | Jan 2013 | B2 |
8357150 | Rosenberg | Jan 2013 | B2 |
D676959 | Flyash et al. | Feb 2013 | S |
D676960 | Flyash et al. | Feb 2013 | S |
8365741 | Hennings et al. | Feb 2013 | B2 |
8409183 | Hennings et al. | Apr 2013 | B2 |
8419726 | Mehta | Apr 2013 | B2 |
8430104 | Hennings et al. | Apr 2013 | B2 |
8439045 | Hennings et al. | May 2013 | B2 |
8448644 | Hennings et al. | May 2013 | B2 |
8454540 | Eshel et al. | Jun 2013 | B2 |
8466605 | Kushculey et al. | Jun 2013 | B2 |
8479624 | Flyash et al. | Jul 2013 | B2 |
8496654 | Rosenberg Avner | Jul 2013 | B2 |
8512327 | Knopp et al. | Aug 2013 | B2 |
8516706 | Flyash et al. | Aug 2013 | B2 |
8540705 | Mehta | Sep 2013 | B2 |
8568339 | Rybyanets | Oct 2013 | B2 |
8573227 | Hennings et al. | Nov 2013 | B2 |
8579896 | Kreindel | Nov 2013 | B2 |
8585693 | Knopp et al. | Nov 2013 | B2 |
8606366 | Flyash et al. | Dec 2013 | B2 |
8608737 | Mehta et al. | Dec 2013 | B2 |
8613741 | Jones et al. | Dec 2013 | B1 |
8641703 | Flyash et al. | Feb 2014 | B2 |
8685012 | Hennings et al. | Apr 2014 | B2 |
8702769 | Eckhouse et al. | Apr 2014 | B2 |
8709011 | Eckhouse et al. | Apr 2014 | B2 |
8771263 | Epshtein et al. | Jul 2014 | B2 |
8771268 | Kreindel | Jul 2014 | B2 |
8778003 | Eckhouse et al. | Jul 2014 | B2 |
8814922 | Hennings et al. | Aug 2014 | B2 |
8906015 | Kreindel | Dec 2014 | B2 |
8936593 | Epshtein et al. | Jan 2015 | B2 |
D724749 | Koby et al. | Mar 2015 | S |
8979830 | Hennings | Mar 2015 | B2 |
8979833 | McGill et al. | Mar 2015 | B2 |
9011419 | Flyash et al. | Mar 2015 | B2 |
9037229 | Bar-El et al. | May 2015 | B2 |
D732679 | Assa et al. | Jun 2015 | S |
D733310 | Assa et al. | Jun 2015 | S |
9084587 | Eckhouse et al. | Jul 2015 | B2 |
D735866 | Assa et al. | Aug 2015 | S |
9144463 | Hennings et al. | Sep 2015 | B2 |
9277958 | Schomacker et al. | Mar 2016 | B2 |
9278230 | Levin et al. | Mar 2016 | B2 |
9314293 | Rosenberg | Mar 2016 | B2 |
9301588 | Eckhouse et al. | Apr 2016 | B2 |
9308046 | Schomacker et al. | Apr 2016 | B2 |
9381057 | Schomacker et al. | Jul 2016 | B2 |
9486285 | Paithankar et al. | Nov 2016 | B2 |
9496678 | Bhawalkar et al. | Nov 2016 | B2 |
9539439 | Jones et al. | Jan 2017 | B2 |
9585687 | Tenenbaum et al. | Mar 2017 | B2 |
9597528 | Schomacker et al. | Mar 2017 | B2 |
9722392 | Bhawalkar et al. | Aug 2017 | B2 |
9889297 | Schomacker | Feb 2018 | B2 |
9895188 | Schomacker et al. | Feb 2018 | B2 |
20040210214 | Knowlton | Oct 2004 | A1 |
20060036300 | Kreindel | Feb 2006 | A1 |
20060047281 | Kreindel | Mar 2006 | A1 |
20060241440 | Eshel et al. | Oct 2006 | A1 |
20070038201 | Koop et al. | Feb 2007 | A1 |
20070073367 | Jones et al. | Mar 2007 | A1 |
20070173799 | Hsia | Jul 2007 | A1 |
20070191827 | Lischinsky et al. | Aug 2007 | A1 |
20070270785 | Jones et al. | Nov 2007 | A1 |
20070287949 | Levin et al. | Dec 2007 | A1 |
20070292445 | Levin | Dec 2007 | A1 |
20080004678 | Kreindel | Jan 2008 | A1 |
20080021527 | Hennings et al. | Jan 2008 | A1 |
20080091179 | Durkin et al. | Apr 2008 | A1 |
20080161888 | Hisa | Jul 2008 | A1 |
20080188846 | Palanker et al. | Aug 2008 | A1 |
20080214988 | Altshuler et al. | Sep 2008 | A1 |
20080215040 | Paithankar et al. | Sep 2008 | A1 |
20080221649 | Echague et al. | Sep 2008 | A1 |
20080269734 | Echague et al. | Oct 2008 | A1 |
20080274166 | Sacks et al. | Nov 2008 | A1 |
20080281236 | Eshel et al. | Nov 2008 | A1 |
20080281389 | Koop et al. | Nov 2008 | A1 |
20090036958 | Mehta | Feb 2009 | A1 |
20090054743 | Stewart | Feb 2009 | A1 |
20090099483 | Rybyanets | Apr 2009 | A1 |
20090105706 | Livneh | Apr 2009 | A1 |
20090112205 | McGill et al. | Apr 2009 | A1 |
20090171251 | Rybyanets et al. | Jul 2009 | A1 |
20090171254 | Goland et al. | Jul 2009 | A1 |
20090186318 | Assa et al. | Jul 2009 | A1 |
20090187175 | Assa et al. | Jul 2009 | A1 |
20090187176 | Assa et al. | Jul 2009 | A1 |
20090210766 | Eckhouse et al. | Aug 2009 | A1 |
20090221938 | Rosenberg et al. | Sep 2009 | A1 |
20090227995 | Bhawalkar et al. | Sep 2009 | A1 |
20100004536 | Rosenberg | Jan 2010 | A1 |
20100010480 | Mehta et al. | Jan 2010 | A1 |
20100010484 | Mehta et al. | Jan 2010 | A1 |
20100016846 | Hennings et al. | Jan 2010 | A1 |
20100017750 | Rosenberg et al. | Jan 2010 | A1 |
20100016727 | Rosenberg | Feb 2010 | A1 |
20100016761 | Rosenberg | Feb 2010 | A1 |
20100042020 | Ben-Ezra | Feb 2010 | A1 |
20100042085 | Hennings et al. | Feb 2010 | A1 |
20100049098 | Shalgi et al. | Feb 2010 | A1 |
20100066918 | Gupta et al. | Mar 2010 | A1 |
20100100014 | Eshel et al. | Apr 2010 | A1 |
20100106064 | Kreindel et al. | Apr 2010 | A1 |
20100106145 | Widgerow | Apr 2010 | A1 |
20100174224 | Sohn | Jul 2010 | A1 |
20100185193 | Kriendel | Jul 2010 | A1 |
20100185194 | Kriendel | Jul 2010 | A1 |
20100198134 | Eckhouse et al. | Aug 2010 | A1 |
20100198199 | Kriendel | Aug 2010 | A1 |
20100198216 | Palanker | Aug 2010 | A1 |
20100204619 | Rosenberg | Aug 2010 | A1 |
20100204694 | Mehta et al. | Aug 2010 | A1 |
20100217254 | Mehta | Aug 2010 | A1 |
20100249772 | Mehta et al. | Sep 2010 | A1 |
20100256617 | Domankevitz et al. | Oct 2010 | A1 |
20100262135 | Berube | Oct 2010 | A1 |
20100293807 | Bar-El et al. | Nov 2010 | A1 |
20110015549 | Eckhouse et al. | Jan 2011 | A1 |
20110129522 | MeVorat-Kaplan et al. | Jun 2011 | A1 |
20110137386 | Kriendel | Jun 2011 | A1 |
20110150976 | Levin et al. | Jun 2011 | A1 |
20110264173 | Flyash et al. | Jul 2011 | A1 |
20110190745 | Uebelhoer et al. | Aug 2011 | A1 |
20110218525 | Hennings et al. | Sep 2011 | A1 |
20110251527 | Kushculey et al. | Oct 2011 | A1 |
20110270364 | Kriendel et al. | Nov 2011 | A1 |
20120004548 | Eshel et al. | Jan 2012 | A1 |
20120022504 | Haim et al. | Jan 2012 | A1 |
20120022627 | Rosenberg | Jan 2012 | A1 |
20120136280 | Rosenberg et al. | May 2012 | A1 |
20120136282 | Rosenberg et al. | May 2012 | A1 |
20120123397 | Haim et al. | Jun 2012 | A1 |
20120143178 | Mehta | Jun 2012 | A9 |
20120150079 | Rosenberg | Jun 2012 | A1 |
20120150168 | Rosenberg | Jun 2012 | A1 |
20120157838 | Adanny et al. | Jun 2012 | A1 |
20120158100 | Schomacker | Jun 2012 | A1 |
20120172869 | McGill et al. | Jul 2012 | A1 |
20120197242 | Rosenberg | Aug 2012 | A1 |
20120270743 | Weisgerber et al. | Oct 2012 | A1 |
20120271219 | Weisgerber et al. | Oct 2012 | A1 |
20120277587 | Adanny et al. | Nov 2012 | A1 |
20120310311 | Elkah | Dec 2012 | A1 |
20130023855 | Hennings et al. | Jan 2013 | A1 |
20130041308 | Hennings et al. | Feb 2013 | A1 |
20130072914 | Domankevitz et al. | Mar 2013 | A1 |
20130123629 | Rosenberg et al. | May 2013 | A1 |
20130150841 | Schomacker et al. | Jun 2013 | A1 |
20130178764 | Eckhouse et al. | Jul 2013 | A1 |
20130211347 | Arbel et al. | Aug 2013 | A1 |
20130218146 | Hennings et al. | Aug 2013 | A1 |
20130226075 | Hennings et al. | Aug 2013 | A1 |
20130261436 | Hennings et al. | Oct 2013 | A1 |
20130261437 | Hennings et al. | Oct 2013 | A1 |
20130261454 | Hennings et al. | Oct 2013 | A1 |
20130274841 | Eckhous et al. | Oct 2013 | A1 |
20130310714 | Eshel et al. | Nov 2013 | A1 |
20140005658 | Rosenbergr | Jan 2014 | A1 |
20140025062 | Rosenberg et al. | Jan 2014 | A1 |
20140081250 | Eckhouse et al. | Mar 2014 | A1 |
20140200564 | Schomacker et al. | Jul 2014 | A1 |
20140214022 | Adanny et al. | Jul 2014 | A1 |
20140221990 | Kreindel | Aug 2014 | A1 |
20140228834 | Adanny et al. | Aug 2014 | A1 |
20140249522 | Adanny et al. | Sep 2014 | A1 |
20140296852 | Adanny et al. | Oct 2014 | A1 |
20150032092 | Addany | Jan 2015 | A1 |
20150250543 | Israeli et al. | Sep 2015 | A1 |
20150265492 | Eckhouse et al. | Sep 2015 | A1 |
20150283026 | Rosenberg | Oct 2015 | A1 |
20150328474 | Flyash et al. | Nov 2015 | A1 |
20150366611 | Rosenberger et al. | Dec 2015 | A1 |
20160045265 | Bhawalkar et al. | Feb 2016 | A1 |
20160143692 | Shang et al. | May 2016 | A1 |
20160367830 | Eisenmann | Dec 2016 | A1 |
20170014174 | Levine et al. | Jan 2017 | A1 |
20170136237 | Rosenberg et al. | May 2017 | A1 |
20170266457 | Eckhouse et al. | Sep 2017 | A1 |
20170304641 | Eisenmann et al. | Oct 2017 | A1 |
Number | Date | Country |
---|---|---|
200017948 | May 2003 | AU |
199964868 | Jan 2005 | AU |
2002307781 | Jan 2007 | AU |
2006209047 | May 2012 | AU |
2011292747 | Mar 2014 | AU |
PI0606804 | Jan 2006 | BR |
2610757 | Dec 2006 | CA |
2696227 | Apr 2009 | CA |
2704740 | Apr 2009 | CA |
2704164 | May 2009 | CA |
2747767 | Sep 2010 | CA |
2356175 | Oct 2011 | CA |
2349169 | Aug 2012 | CA |
200680003537.7 | Jan 2006 | CN |
200780008298.9 | Jul 2007 | CN |
101232852 | Jul 2008 | CN |
200880019693.1 | Jun 2013 | CN |
200880101512.X | Jun 2013 | CN |
0569670 | Nov 1993 | EP |
1140280 | Dec 1999 | EP |
2272455 | Sep 2001 | EP |
1502622 | Apr 2002 | EP |
2286751 | Mar 2003 | EP |
1320333 | Jun 2003 | EP |
1850781 | Jan 2006 | EP |
2527005 | Feb 2007 | EP |
1852060 | Nov 2007 | EP |
1863569 | Dec 2007 | EP |
1888001 | Dec 2007 | EP |
2200666 | Oct 2008 | EP |
2205967 | Oct 2008 | EP |
2211918 | Oct 2008 | EP |
1502622 | Jun 2009 | EP |
2393444 | Feb 2010 | EP |
2401026 | Feb 2010 | EP |
2730313 | Feb 2010 | EP |
2319445 | Sep 2010 | EP |
2319577 | May 2011 | EP |
2394594 | Dec 2011 | EP |
2139560 | May 2012 | EP |
2205967 | May 2013 | EP |
2190525 | Jul 2013 | EP |
2605718 | Mar 2014 | EP |
1499255 | Jul 2015 | EP |
1955731 | Aug 2015 | EP |
1128870 | Aug 2016 | EP |
1450876 | Aug 2016 | EP |
1502622 | Apr 2002 | FR |
1320333 | Jun 2003 | FR |
1320333 | Jun 2003 | GB |
181112 | Aug 2005 | IL |
188968 | Jul 2006 | IL |
202907 | Jan 2007 | IL |
193497 | Feb 2007 | IL |
143014 | Sep 2007 | IL |
187608 | Nov 2007 | IL |
202558 | Jun 2008 | IL |
206652 | Dec 2008 | IL |
206654 | Dec 2008 | IL |
213561 | Jun 2011 | IL |
158582 | Feb 2012 | IL |
219219 | Apr 2012 | IL |
184869 | May 2012 | IL |
226319 | May 2013 | IL |
203339 | Jul 2014 | IL |
200992 | Aug 2014 | IL |
204969 | Mar 2015 | IL |
4745500 | May 2000 | JP |
2008-515379 | May 2008 | JP |
4837723 | Aug 2008 | JP |
4262985 | Feb 2009 | JP |
2009-527269 | Jul 2009 | JP |
4335522 | Jul 2009 | JP |
4382991 | Oct 2009 | JP |
4452511 | Feb 2010 | JP |
2010-528803 | Aug 2010 | JP |
4638130 | Dec 2010 | JP |
5507022011 | Jun 2011 | JP |
2011-237691 | Nov 2011 | JP |
5116488 | Oct 2012 | JP |
2012-542684 | Apr 2013 | JP |
5294852 | Jun 2013 | JP |
2013-538323 | Oct 2013 | JP |
5389025 | Oct 2013 | JP |
5466161 | Jan 2014 | JP |
5508272 | Mar 2014 | JP |
5612474 | Sep 2014 | JP |
5620458 | Sep 2014 | JP |
5934211 | May 2016 | JP |
10-2007-0116253 | Dec 2007 | KR |
10-2008-0025028 | Mar 2008 | KR |
10-2010-0044161 | Apr 2010 | KR |
10-2010-0065297 | Jun 2010 | KR |
10-2012-0037011 | Apr 2012 | KR |
2012-0111725 | Oct 2012 | KR |
10-1227286 | Jan 2013 | KR |
10-1246980 | Mar 2013 | KR |
10-1272372 | May 2013 | KR |
2013-0128391 | Nov 2013 | KR |
1679467 | Nov 2016 | KR |
WO 0038781 | Jul 2000 | WO |
WO 01085234 | Nov 2001 | WO |
WO 02092163 | Nov 2002 | WO |
WO 2007013072 | Feb 2007 | WO |
WO 2007093998 | Aug 2007 | WO |
WO 2008091625 | Jul 2008 | WO |
WO 2008152630 | Dec 2008 | WO |
WO 2009057112 | May 2009 | WO |
WO 2010097790 | Sep 2010 | WO |
WO 2010115196 | Oct 2010 | WO |
WO 2011067771 | Jun 2011 | WO |
WO 2012011098 | Jan 2012 | WO |
WO 2012023129 | Feb 2012 | WO |
WO 2012063236 | May 2012 | WO |
WO 2014141229 | Sep 2014 | WO |
WO 2017130185 | Aug 2017 | WO |
Entry |
---|
Guidelines for Limiting Exposure to Time-Varying Electric, Magnetic, and Electromagnetic Fields (Up to 300 GHz), International Commission on Non-Ionizing Radiation Protection, ICNIRP Guidelines, Apr. 1998, vol. 74, No. 4, pp. 496-522. |
Number | Date | Country | |
---|---|---|---|
20150297283 A1 | Oct 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14252832 | Apr 2014 | US |
Child | 14791840 | US | |
Parent | 13400434 | Feb 2012 | US |
Child | 14252832 | US | |
Parent | 12505576 | Jul 2009 | US |
Child | 13400434 | US |